PRDM1 is directly targeted by miR-30a-5p and modulates the Wnt/β-catenin pathway in a Dkk1-dependent manner during glioma growth

Cancer Letters

Volumn 331, Issue 2, 2013, Pages 211-219

  Wang, Xuan ^a   Wang, Kun ^b   Han, Lei ^c,d   Zhang, Anling ^c,d   Shi, Zhendong ^c,d   Zhang, Kailiang ^c,d   Zhang, Hongwei ^a   Yang, Shaohua ^e   Pu, Peiyu ^c,d   Shen, Changhong ^c   Yu, Chunjiang ^a   Kang, Chunsheng ^c,d  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY   (China)

^c TIANJIN MEDICAL UNIVERSITY   (China)

^d Chinese Glioma Cooperative Group   (China)

^e UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

Author keywords

Catenin; Dkk1; Glioma; MiR 30a 5p; PRDM1

Indexed keywords

B LYMPHOCYTE INDUCED MATURATION PROTEIN 1; BETA CATENIN; DICKKOPF 1 PROTEIN; MICRORNA; MICRORNA 30A 5P; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BIOINFORMATICS; CANCER GRADING; CELL INVASION; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE SPECIFIC SURVIVAL; GENE REPRESSION; GLIOMA; GLIOMA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SURVIVAL PREDICTION; SURVIVAL TIME; TUMOR GROWTH; WNT SIGNALING PATHWAY;

ANIMALS; BETA CATENIN; BRAIN NEOPLASMS; CELL DIVISION; GLIOMA; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MICE, INBRED BALB C; MICE, NUDE; MICRORNAS; REAL-TIME POLYMERASE CHAIN REACTION; REPRESSOR PROTEINS; RETROSPECTIVE STUDIES; SIGNAL TRANSDUCTION; WNT PROTEINS;

EID: 84875372768     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2013.01.005     Document Type: Article

References (53)

1. Ohgaki H., Kleihues P. Epidemiology and etiology of gliomas. Acta Neuropathol. 2005, 109:93-108.
2. Mueller S., Haas-Kogan D. High-grade gliomas. Pediatric CNS Tumors 2010, 37-48. Springer, Berlin. N. Gupta, A. Banerjee, D. Haas-Kogan (Eds.).
3. Sanchez-Mejia R.O., Banerjee A., Gupta N. Supratentorial high-grade gliomas. Neuro-Oncology of CNS Tumors 2006, 385-391. Springer, Berlin. J.-C. Tonn, S.A. Grossman, J.T. Rutka, M. Westphal (Eds.).
4. Saran F. Recent advances in pediatric neuro-oncology. Curr. Opin. Neurol. 2002, 15:671-677.
5. Miller R.W., Young J.L., Novakovic B. Childhood cancer. Cancer 1995, 75:395-405.
6. Federico S., Brennan R., Dyer M.A. Childhood cancer and developmental biology a crucial partnership. Curr. Top Dev. Biol. 2011, 94:1-13.
7. Wechsler-Reya R., Scott M.P. The developmental biology of brain tumors. Annu. Rev. Neurosci. 2001, 24:385-428.
8. Edwards P.A. The impact of developmental biology on cancer research: an overview. Cancer Metastasis Rev. 1999, 18:175-180.
9. Keller A.D., Maniatis T. Identification and characterization of a novel repressor of beta-interferon gene expression. Genes Dev. 1991, 5:868-879.
10. Bikoff E.K., Morgan M.A., Robertson E.J. An expanding job description for Blimp-1/PRDM1. Curr. Opin. Genet. Dev. 2009, 19:379-385.
11. John S.A., Garrett-Sinha L.A. Blimp1: a conserved transcriptional repressor critical for differentiation of many tissues. Exp. Cell Res. 2009, 315:1077-1084.
12. Shaffer A.L., Lin K.I., Kuo T.C., Yu X., Hurt E.M., Rosenwald A., Giltnane J.M., Yang L., Zhao H., Calame K., Staudt L.M. Blimp-1 orchestrates plasma cell differentiation by extinguishing the mature B cell gene expression program. Immunity 2002, 17:51-62.
13. Shapiro-Shelef M., Calame K. Regulation of plasma-cell development. Nat. Rev. Immunol. 2005, 5:230-242.
14. Hangaishi A., Kurokawa M. Blimp-1 is a tumor suppressor gene in lymphoid malignancies. Int. J. Hematol. 2010, 91:46-53.
15. Meani N., Pezzimenti F., Deflorian G., Mione M., Alcalay M. The tumor suppressor PRDM5 regulates Wnt signaling at early stages of zebrafish development. PLoS ONE 2009, 4:e4273.
16. Cheng H.Y., Chen X.W., Cheng L., Liu Y.D., Lou G. DNA methylation and carcinogenesis of PRDM5 in cervical cancer. J. Cancer Res. Clin Oncol 2010, 136:1821-1825.
17. Nishikawa N., Toyota M., Suzuki H., Honma T., Fujikane T., Ohmura T., Nishidate T., Ohe-Toyota M., Maruyama R., Sonoda T., Sasaki Y., Urano T., Imai K., Hirata K., Tokino T. Gene amplification and overexpression of PRDM14 in breast cancers. Cancer Res. 2007, 67:9649-9657.
18. Nishikata I., Sasaki H., Iga M., Tateno Y., Imayoshi S., Asou N., Nakamura T., Morishita K. A novel EVI1 gene family, MEL1, lacking a PR domain (MEL1S) is expressed mainly in t(1;3) (p36;q21)-positive AML and blocks G-CSF-induced myeloid differentiation. Blood 2003, 102:3323-3332.
19. Reid A.G., Nacheva E.P. A potential role for PRDM12 in the pathogenesis of chronic myeloid leukaemia with derivative chromosome 9 deletion. Leukemia 2004, 18:178-180.
20. Yang X.H., Huang S. PFM1 (PRDM4), a new member of the PR-domain family, maps to a tumor suppressor locus on human chromosome 12q23-q24.1. Genomics 1999, 61:319-325.
21. Nie K., Gomez M., Landgraf P., Garcia J.F., Liu Y., Tan L.H., Chadburn A., Tuschl T., Knowles D.M., Tam W. MicroRNA-mediated down-regulation of PRDM1/Blimp-1 in Hodgkin/Reed-Sternberg cells: a potential pathogenetic lesion in Hodgkin lymphomas. Am. J. Pathol. 2008, 173:242-252.
22. Nikitina N., Tong L., Bronner M.E. Ancestral network module regulating prdm1 expression in the lamprey neural plate border. Dev. Dyn. 2011, 240:2265-2271.
23. Hernandez-Lagunas L., Choi I.F., Kaji T., Simpson P., Hershey C., Zhou Y., Zon L., Mercola M., Artinger K.B. Zebrafish narrowminded disrupts the transcription factor prdm1 and is required for neural crest and sensory neuron specification. Dev. Biol. 2005, 278:347-357.
24. Roy S., Ng T. Blimp-1 specifies neural crest and sensory neuron progenitors in the zebrafish embryo. Curr. Biol. 2004, 14:1772-1777.
25. de Souza F.S., Gawantka V., Gomez A.P., Delius H., Ang S.L., Niehrs C. The zinc finger gene Xblimp1 controls anterior endomesodermal cell fate in Spemann's organizer. EMBO J. 1999, 18:6062-6072.
26. Baxendale S., Davison C., Muxworthy C., Wolff C., Ingham P.W., Roy S. The B-cell maturation factor Blimp-1 specifies vertebrate slow-twitch muscle fiber identity in response to Hedgehog signaling. Nat. Genet. 2004, 36:88-93.
27. Vincent S.D., Dunn N.R., Sciammas R., Shapiro-Shalef M., Davis M.M., Calame K., Bikoff E.K., Robertson E.J. The zinc finger transcriptional repressor Blimp1/Prdm1 is dispensable for early axis formation but is required for specification of primordial germ cells in the mouse. Development 2005, 132:1315-1325.
28. Ohinata Y., Sano M., Shigeta M., Yamanaka K., Saitou M. A comprehensive, non-invasive visualization of primordial germ cell development in mice by the Prdm1-mVenus and Dpp a3-ECFP double transgenic reporter. Reproduction 2008, 136:503-514.
29. Scolding N., Franklin R., Stevens S., Heldin C.H., Compston A., Newcombe J. Oligodendrocyte progenitors are present in the normal adult human CNS and in the lesions of multiple sclerosis. Brain 1998, 121(Pt 12):2221-2228.
30. Nunes M.C., Roy N.S., Keyoung H.M., Goodman R.R., McKhann G., Jiang L., Kang J., Nedergaard M., Goldman S.A. Identification and isolation of multipotential neural progenitor cells from the subcortical white matter of the adult human brain. Nat. Med. 2003, 9:439-447.
31. Kinameri E., Inoue T., Aruga J., Imayoshi I., Kageyama R., Shimogori T., Moore A.W. PRDM proto-oncogene transcription factor family expression and interaction with the Notch-Hes pathway in mouse neurogenesis. PLoS ONE 2008, 3:e3859.
32. Minokawa T., Wikramanayake A.H., Davidson E.H. Cis-regulatory inputs of the wnt8 gene in the sea urchin endomesoderm network. Dev Biol. 2005, 288:545-558.
33. Davidson E.H., Rast J.P., Oliveri P., Ransick A., Calestani C., Yuh C.H., Minokawa T., Amore G., Hinman V., Arenas-Mena C., Otim O., Brown C.T., Livi C.B., Lee P.Y., Revilla R., Rust A.G., Pan Z., Schilstra M.J., Clarke P.J., Arnone M.I., Rowen L., Cameron R.A., McClay D.R., Hood L., Bolouri H. A genomic regulatory network for development. Science 2002, 295:1669-1678.
34. Mercader N., Fischer S., Neumann C.J. Prdm1 acts downstream of a sequential RA, Wnt and Fgf signaling cascade during zebrafish forelimb induction. Development 2006, 133:2805-2815.
35. Zhang L., Yang X., Yang S., Zhang J. The Wnt/beta-catenin signaling pathway in the adult neurogenesis. Eur. J. Neurosci. 2011, 33:1-8.
36. Kuwabara T., Hsieh J., Muotri A., Yeo G., Warashina M., Lie D.C., Moore L., Nakashima K., Asashima M., Gage F.H. Wnt-mediated activation of NeuroD1 and retro-elements during adult neurogenesis. Nat. Neurosci. 2009, 12:1097-1105.
37. Gulacsi A.A., Anderson S.A. Beta-catenin-mediated Wnt signaling regulates neurogenesis in the ventral telencephalon. Nat. Neurosci. 2008, 11:1383-1391.
38. Kasai M., Satoh K., Akiyama T. Wnt signaling regulates the sequential onset of neurogenesis and gliogenesis via induction of BMPs. Genes Cells 2005, 10:777-783.
39. Pu P., Zhang Z., Kang C., Jiang R., Jia Z., Wang G., Jiang H. Downregulation of Wnt2 and beta-catenin by siRNA suppresses malignant glioma cell growth. Cancer Gene Ther. 2009, 16:351-361.
40. Zhang J., Huang K., Shi Z., Zou J., Wang Y., Jia Z., Zhang A., Han L., Yue X., Liu N., Jiang T., You Y., Pu P., Kang C. High beta-catenin/Tcf-4 activity confers glioma progression via direct regulation of AKT2 gene expression. Neuro Oncol 2011, 13:600-609.
41. Chen L., Han L., Zhang K., Shi Z., Zhang J., Zhang A., Wang Y., Song Y., Li Y., Jiang T., Pu P., Jiang C., Kang C. VHL regulates the effects of miR-23b on glioma survival and invasion via suppression of HIF-1alpha/VEGF and beta-catenin/Tcf-4 signaling. Neuro Oncol. 2012, 14:1026-1036.
42. Shi Z., Qian X., Li L., Zhang J., Zhu S., Zhu J., Chen L., Zhang K., Han L., Yu S., Pu P., Jiang T., Kang C. Nuclear translocation of beta-catenin is essential for glioma cell survival. J Neuroimmune Pharmacol. 2012, 7:892-903.
43. Zhang K., Zhang J., Han L., Pu P., Kang C. Wnt/beta-catenin signaling in glioma. J Neuroimmune Pharmacol. 2012, 7:740-749.
44. Foltz G., Yoon J.G., Lee H., Ma L., Tian Q., Hood L., Madan A. Epigenetic regulation of wnt pathway antagonists in human glioblastoma multiforme. Genes Cancer 2010, 1:81-90.
45. Gotze S., Wolter M., Reifenberger G., Muller O., Sievers S. Frequent promoter hypermethylation of Wnt pathway inhibitor genes in malignant astrocytic gliomas. Int. J. Cancer 2010, 126:2584-2593.
46. MacDonald B.T., Tamai K., He X. Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev. Cell 2009, 17:9-26.
47. Kahlert U.D., Maciaczyk D., Doostkam S., Orr B.A., Simons B., Bogiel T., Reithmeier T., Prinz M., Schubert J., Niedermann G., Brabletz T., Eberhart C.G., Nikkhah G., Maciaczyk J. Activation of canonical Wnt/beta-catenin signaling enhances in vitro motility of glioblastoma cells by activation of ZEB1 and other activators of epithelial-to-mesenchymal transition. Cancer Lett. 2012, 325:42-53.
48. Shi Z., Qian X., Li L., Zhang J., Zhu S., Zhu J., Chen L., Zhang K., Han L., Yu S., Pu P., Jiang T., Kang C. Nuclear translocation of beta-catenin is essential for glioma cell survival. J. Neuroimmune Pharmacol. 2012.
49. Yochum G.S., Cleland R., Goodman R.H. A genome-wide screen for beta-catenin binding sites identifies a downstream enhancer element that controls c-myc gene expression. Mol. Cell. Biol. 2008, 28:7368-7379.
50. Caneparo L., Huang Y.L., Staudt N., Tada M., Ahrendt R., Kazanskaya O., Niehrs C., Houart C. Dickkopf-1 regulates gastrulation movements by coordinated modulation of Wnt/beta catenin and Wnt/PCP activities, through interaction with the Dally-like homolog Knypek. Genes Dev. 2007, 21:465-480.
51. Baulcombe D. DNA events. An RNA microcosm. Science 2002, 297:2002-2003.
52. Pang J.C., Kwok W.K., Chen Z., Ng H.K. Oncogenic role of microRNAs in brain tumors. Acta Neuropathol. 2009, 117:599-611.
53. Huang K., Zhang J.X., Han L., You Y.P., Jiang T., Pu P.Y., Kang C.S. MicroRNA roles in beta-catenin pathway. Mol. Cancer 2010, 9:252.